Antibodies

The study notes the obstacle to creating a vaccine that can induce strong antibodies that can neutralize HIV strains.

Researchers at Tel Aviv University found two antibodies that neutralize all known strains of COVID-19 with up to 95% efficiency.

Researchers discovered that in early 2022, hospitals administered 158,000 doses of unauthorized monoclonal antibody treatments.

The antibody in question was easily induced in rhesus macaque monkeys and provided broad protection against not just COVID-19 and variants but other SARS viruses.

Blood cancer patients, already at high risk, often did not develop antibodies against COVID-19 from the first shot. But the booster and antibody therapy can provide a better shield.

The study, conducted at Mount Sinai, is one of the first to successfully measure T cell responses, which may be able to ensure protection after antibodies are gone.

Natural antibodies found in tumors could point the way toward improved immunotherapy, according to a new Weizmann Institute study, a potential cancer breakthrough.

Study shows that children infected with COVID-19 continue to have antibodies at least six months afterwards, but protection against Omicron still unclear.

Evusheld is a new medication from AstraZeneca designed specifically for people who are immunocompromised.

Even low levels of antibodies would continue to provide some protection against disease, the researchers said — as long as the virus doesn’t change.